Alcohol intake and long-term mortality risk after myocardial infarction in the Alpha Omega Cohort

Esther Cruijsen, Anne J de Ruiter, Leanne K Küpers, Maria C Busstra, Johanna M Geleijnse, Esther Cruijsen, Anne J de Ruiter, Leanne K Küpers, Maria C Busstra, Johanna M Geleijnse

Abstract

Background: Population-based studies generally show J-shaped associations between alcohol intake and mortality from cardiovascular disease (CVD). Little is known about alcohol and long-term mortality risk after myocardial infarction (MI).

Objectives: We examined alcohol intake in relation to all-cause, CVD, and ischemic heart disease (IHD) mortality in Dutch post-MI patients of the Alpha Omega Cohort.

Methods: The analysis comprised 4365 patients (60-80 years; 79% male) with an MI ≤ 10 years before study enrolment. We used a 203-item FFQ to assess alcohol (total ethanol) and dietary intakes over the past month. Patients were classified as nondrinkers (0 g/d; n = 956) or very light (>0 to 2 g/d; n = 385), light (M: >2 to 10 g/d; F: >2 to 5 g/d; n = 1125), moderate (M: >10 to 30 g/d; F: >5 to 15 g/d; n = 1207), or heavy drinkers (M: >30 g/d; F: >15 g/d; n = 692). HRs of mortality for alcohol intake were obtained from Cox models, adjusting for age, sex, education, smoking, BMI, physical activity, and dietary factors.

Results: Alcohol was consumed by 83% of males and 61% of females. During ∼12 years of follow-up, 2035 deaths occurred, of which 903 were from CVD and 558 were from IHD. Compared to the (combined) reference group of nondrinkers and very light drinkers, HRs for all-cause mortality were 0.87 (95% CI, 0.78-0.98), 0.85 (95% CI, 0.75-0.96), and 0.91 (95% CI, 0.79-1.04) for light, moderate, and heavy drinkers, respectively. For CVD mortality, corresponding HRs were 0.80 (95% CI, 0.67-0.96), 0.82 (95% CI, 0.69-0.98), and 0.87 (95% CI, 0.70-1.08) for light, moderate, and heavy drinkers, respectively. Findings for IHD mortality were similar. HRs did not materially change when nondrinkers or very light drinkers were taken as the reference, or after exclusion of former drinkers or patients with diabetes or poor/moderate self-rated health.

Conclusions: Light and moderate alcohol intakes were inversely associated with mortality risk in stable post-MI patients. These observational findings should be cautiously interpreted in light of the total evidence on alcohol and health. The Alpha Omega Cohort is registered at clinicaltrials.gov as NCT03192410.

Keywords: Alpha Omega Cohort; alcohol; cardiovascular disease; ischemic heart disease; mortality; myocardial infarction; patients; prospective cohort study.

© The Author(s) 2021. Published by Oxford University Press.

Figures

FIGURE 1
FIGURE 1
Associations of alcohol intake with all-cause, CVD, and IHD mortality in 4365 patients from the Alpha Omega Cohort. Lines are restricted cubic splines, showing continuous associations, with 3 knots located at the 5th, 50th, and 95th percentiles. The y-axis shows the predicted HRs for mortality for any value of alcohol intake, compared to the reference value set at 0 g/d. HRs are adjusted for age; sex; obesity; smoking; physical activity; education level; energy intake, excluding energy from alcohol; and intakes of sugar-sweetened beverages, red and processed meat, whole grains, fruits, vegetables, coffee, tea, milk, fish, and salt from foods. CVD, cardiovascular disease; IHD, ischemic heart disease.

References

    1. Griswold MG, Fullman N, Hawley C, Arian N, Zimsen SR, Tymeson HD, Venkateswaran V, Tapp AD, Forouzanfar MH, Salama JS. Alcohol use and burden for 195 countries and territories, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet North Am Ed. 2018;392(10152):1015–35.
    1. Wood AM, Kaptoge S, Butterworth AS, Willeit P, Warnakula S, Bolton T, Paige E, Paul DS, Sweeting M, Burgess S. Risk thresholds for alcohol consumption: Combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet North Am Ed. 2018;391(10129):1513–23.
    1. Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: A systematic review and meta-analysis. BMJ. 2011;342:d671.
    1. Costanzo S, de Gaetano G, Di Castelnuovo A, Djoussé L, Poli A, van Velden DP. Moderate alcohol consumption and lower total mortality risk: Justified doubts or established facts?. Nutr Metab Cardiovasc Dis. 2019;29(10):1003–8.
    1. Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Cheng S, Delling FN. Heart disease and stroke statistics–2021 update: A report from the American Heart Association. Circulation. 2021;143(8):e254–743.
    1. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes: The task force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J. 2020;41(3):407–77.
    1. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, Douglas PS, Foody JM, Gerber TC, Hinderliter AL. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012;60(24):e44–e164.
    1. Costanzo S, Di Castelnuovo A, Donati MB, Iacoviello L, De Gaetano G. Cardiovascular and overall mortality risk in relation to alcohol consumption in patients with cardiovascular disease. Circulation. 2010;121(17):1951–9.
    1. Muntwyler J, Hennekens CH, Buring JE, Gaziano JM. Mortality and light to moderate alcohol consumption after myocardial infarction. Lancet North Am Ed. 1998;352(9144):1882–5.
    1. Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA. Prior alcohol consumption and mortality following acute myocardial infarction. JAMA. 2001;285(15):1965–70.
    1. Aguilar D, Skali H, Moyé LA, Lewis EF, Gaziano JM, Rutherford JD, Hartley LH, Randall OS, Geltman EM, Lamas GA. Alcohol consumption and prognosis in patients with left ventricular systolic dysfunction after a myocardial infarction. J Am Coll Cardiol. 2004;43(11):2015–21.
    1. Janszky I, Ljung R, Ahnve S, Hallqvist J, Bennet AM, Mukamal KJ. Alcohol and long-term prognosis after a first acute myocardial infarction: The SHEEP study. Eur Heart J. 2008;29(1):45–53.
    1. Kesse E, Clavel-Chapelon F, Slimani N, van Liere M, Group EN. Do eating habits differ according to alcohol consumption? Results of a study of the French cohort of the European Prospective Investigation into Cancer and Nutrition (E3N-EPIC). Am J Clin Nutr. 2001;74(3):322–7.
    1. Geleijnse JM, Giltay EJ, Schouten EG, de Goede J, Griep LMO, Teitsma-Jansen AM, Katan MB, Kromhout D, Group AOT. Effect of low doses of n-3 fatty acids on cardiovascular diseases in 4,837 post-myocardial infarction patients: Design and baseline characteristics of the Alpha Omega Trial. Am Heart J. 2010;159(4):539–546.e2.
    1. Kromhout D, Giltay EJ, Geleijnse JM. n–3 Fatty acids and cardiovascular events after myocardial infarction. N Engl J Med. 2010;363(21):2015–26.
    1. Sijtsma FP, Soedamah-Muthu SS, De Goede J, Oude Griep LM, Geleijnse JM, Giltay EJ, De Boer MJ, JacobsDR, JrJr, Kromhout D. Healthy eating and lower mortality risk in a large cohort of cardiac patients who received state-of-the-art drug treatment. Am J Clin Nutr. 2015;102(6):1527–33.
    1. Feunekes GI, Van Staveren WA, De Vries J, Burema J, Hautvast J. Relative and biomarker-based validity of a food-frequency questionnaire estimating intake of fats and cholesterol. Am J Clin Nutr. 1993;58(4):489–96.
    1. Dutch Nutrition Center . Dutch Food Composition Table 2006 NEVO-table. The Hague, Netherlands: Nederlands Voedingsstoffenbestand/NEVO Foundation; 2006.
    1. Baraona E, Abittan CS, Dohmen K, Moretti M, Pozzato G, Chayes ZW, Schaefer C, Lieber CS. Gender differences in pharmacokinetics of alcohol. Alcohol Clin Exp Res. 2001;25(4):502–7.
    1. World Health Organization . International statistical classification of diseases and related health problems. Geneva, Switzerland: World Health Organization; 2004.
    1. Schuit AJ, Schouten EG, Westerterp KR, Saris WH. Validity of the Physical Activity Scale for the Elderly (PASE): According to energy expenditure assessed by the doubly labeled water method. J Clin Epidemiol. 1997;50(5):541–6.
    1. World Health Organization . The anatomical therapeutic chemical classification system with defined daily doses-ATC/DDD. Oslo, Norway: World Health Organization; 2009.
    1. Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med. 2010;29(9):1037–57.
    1. U.S. Department of Agriculture and U.S; Department of Health and Human Services. Dietary guidelines for Americans, 2020–5.. 9th ed. 2020. [Internet]. Available from:.
    1. Davies NM, Holmes MV, Smith GD. Reading Mendelian randomisation studies: A guide, glossary, and checklist for clinicians. BMJ. 2018;362:k601.
    1. Millwood IY, Walters RG, Mei XW, Guo Y, Yang L, Bian Z, Bennett DA, Chen Y, Dong C, Hu R. Conventional and genetic evidence on alcohol and vascular disease aetiology: A prospective study of 500 000 men and women in China. Lancet North Am Ed. 2019;393(10183):1831–42.
    1. Koellinger PD, De Vlaming R. Mendelian randomization: The challenge of unobserved environmental confounds. Int J Epidemiol. 2019;48(3):665–71.
    1. Brien SE, Ronksley PE, Turner BJ, Mukamal KJ, Ghali WA. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: Systematic review and meta-analysis of interventional studies. BMJ. 2011;342:d636.
    1. Jones A, McMillan MR, Jones RW, Kowalik GT, Steeden JA, Pruessner JC, Taylor AM, Deanfield JE, Muthurangu V. Habitual alcohol consumption is associated with lower cardiovascular stress responses–A novel explanation for the known cardiovascular benefits of alcohol?. Stress. 2013;16(4):369–76.
    1. Zhao P-P, Xu L-W, Sun T, Wu Y-Y, Zhu X-W, Zhang B, Cheng Z, Cai X, Liu Y-C, Zhao T-T. Relationship between alcohol use, blood pressure and hypertension: An association study and a Mendelian randomisation study. J Epidemiol Community Health. 2019;73(9):796–801.
    1. Roerecke M, Kaczorowski J, Tobe SW, Gmel G, Hasan OS, Rehm J. The effect of a reduction in alcohol consumption on blood pressure: A systematic review and meta-analysis. Lancet Public Health. 2017;2(2):e108–e20.
    1. Csengeri D, Sprünker N-A, Di Castelnuovo A, Niiranen T, Vishram-Nielsen JK, Costanzo S, Söderberg S, Jensen SM, Vartiainen E, Donati MB. Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes. Eur Heart J. 2021;42(12):1170–7.
    1. Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet North Am Ed. 2009;373(9682):2223–33.
    1. Roerecke M, Rehm J. Irregular heavy drinking occasions and risk of ischemic heart disease: A systematic review and meta-analysis. Am J Epidemiol. 2010;171(6):633–44.
    1. Xi B, Veeranki SP, Zhao M, Ma C, Yan Y, Mi J. Relationship of alcohol consumption to all-cause, cardiovascular, and cancer-related mortality in US adults. J Am Coll Cardiol. 2017;70(8):913–22.

Source: PubMed

3
Subskrybuj